摘要：
9月21日, 北京大学药学院天然药物及仿生药物全国重点实验室汪贻广教授在国际著名期刊Nature Communications在线刊登了最新研究成果“pH-gated nanoparticles selectively regulate lysosomal function of tumour-associated macrophages for cancer immunotherapy”(pH门控纳米佐剂特异性调控肿瘤相关巨噬细胞的溶酶体功能实现肿瘤免疫治疗)。
Supporting:
北京大学药学院 天然药物及仿生药物国家重点实验室. 汪贻广团队发展特异性调控肿瘤相关巨噬细胞溶酶体功能的新策略[J]. 中国药学(英文版), 2023, 32(9): 772-772.
State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center. The research team of Prof. Yiguang Wang developed a new strategy for specifically regulating the lysosomal function of tumor-associated macrophages for cancer immunotherapy[J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(9): 772-772.
>
>